Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
26932 | 199 | 41.6 | 95% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CCL20 | Author keyword | 19 | 36% | 22% | 44 |
2 | CCR6 | Author keyword | 16 | 36% | 18% | 35 |
3 | MACROPHAGE INFLAMMATORY PROTEIN 3 ALPHA | Author keyword | 7 | 56% | 5% | 9 |
4 | MIP 3 ALPHA | Author keyword | 3 | 37% | 4% | 7 |
5 | HEMATOL MED ONCOL TRANSFUS MED | Address | 1 | 100% | 1% | 2 |
6 | MACROPHAGE INFLAMMATORY PROTEIN 3 ALPHA MIP 3 ALPHA | Author keyword | 1 | 100% | 1% | 2 |
7 | MED INFORMAT BIOMETRY CLIN EPIDEMIOL | Address | 1 | 50% | 1% | 2 |
8 | CHEMOKINE BIOL | Address | 1 | 17% | 3% | 5 |
9 | BIOMETR EPIDEMIOL MED INFORMAT | Address | 1 | 50% | 1% | 1 |
10 | CC CHEMOKINE RECEPTOR 6 CCR6 | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MIP 3 ALPHA | 27 | 78% | 9% | 18 |
2 | REGULATED CHEMOKINE LARC | 19 | 80% | 6% | 12 |
3 | INFLAMMATORY PROTEIN 3 ALPHA | 18 | 32% | 24% | 47 |
4 | PROTEIN 3 ALPHA | 14 | 50% | 10% | 20 |
5 | CHEMOKINE RECEPTOR CCR6 | 13 | 50% | 10% | 19 |
6 | RECEPTOR CCR6 | 9 | 44% | 8% | 15 |
7 | CCL20 | 6 | 37% | 7% | 13 |
8 | MIP 3 ALPHA CCL20 | 6 | 100% | 2% | 4 |
9 | CC CHEMOKINE RECEPTOR 6 | 4 | 75% | 2% | 3 |
10 | CHEMOKINE CCL20 | 4 | 50% | 3% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CCR6 as a mediator of immunity in the lung and gut | 2011 | 39 | 57 | 49% |
The relationship between CCR6 and its binding partners: Does the CCR6-CCL20 axis have to be extended? | 2015 | 1 | 60 | 38% |
The CC chemokine CCL20 and its receptor CCR6 | 2003 | 306 | 129 | 38% |
CC chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: odd couple or axis of evil? | 2013 | 13 | 74 | 34% |
The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer | 2009 | 55 | 42 | 33% |
CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis | 2014 | 4 | 67 | 31% |
An immune paradox: How can the same chemokine axis regulate both immune tolerance and activation? CCR6/CCL20: A chemokine axis balancing immunological tolerance and inflammation in autoimmune disease | 2010 | 28 | 92 | 25% |
The Increased Expression of CCL20 and CCR6 in Rectal Mucosa Correlated to Severe Inflammation in Pediatric Ulcerative Colitis | 2015 | 0 | 20 | 60% |
CCR6 as a possible therapeutic target in psoriasis | 2010 | 12 | 145 | 13% |
Chemokines and dendritic cells: A crucial alliance | 2002 | 65 | 100 | 8% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEMATOL MED ONCOL TRANSFUS MED | 1 | 100% | 1.0% | 2 |
2 | MED INFORMAT BIOMETRY CLIN EPIDEMIOL | 1 | 50% | 1.0% | 2 |
3 | CHEMOKINE BIOL | 1 | 17% | 2.5% | 5 |
4 | BIOMETR EPIDEMIOL MED INFORMAT | 1 | 50% | 0.5% | 1 |
5 | HOSP SW | 1 | 50% | 0.5% | 1 |
6 | INFLAMMAT TISSUS EPITHELIAUX CYTOKINES EA 4 | 1 | 50% | 0.5% | 1 |
7 | REGENERAT MED INFLAMMAT | 1 | 50% | 0.5% | 1 |
8 | U255 RECH BIOMED CORDELIERS | 1 | 50% | 0.5% | 1 |
9 | UNIDAD ANIM TRANSGEN EXPT | 1 | 50% | 0.5% | 1 |
10 | MED SCI MOL GASTROENTEROL HEPATOL | 0 | 33% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000250285 | THYMUS AND ACTIVATION REGULATED CHEMOKINE//TARC//CCR4 |
2 | 0.0000181081 | INTESTINAL EPITHELIAL//CRI 4U004B//LUMINAL CYTOKINES |
3 | 0.0000164050 | CCR2 ANTAGONIST//CCR2//CCR2 ANTAGONISTS |
4 | 0.0000155709 | SEXUALLY TRANSMITTED VIRUS//MICHAEL DEGROOTE LEARNING DISCOVERY//HUMAN CERVIX |
5 | 0.0000142905 | CXCR4//CXCR7//CXCL12 |
6 | 0.0000138361 | BB 10010//CK BETA 8//STEM CELL INHIBITOR |
7 | 0.0000127203 | EOTAXIN//CCR3//RANTES |
8 | 0.0000124106 | LYMPHOTOXIN//LT BETA R//BTLA |
9 | 0.0000118242 | CCR9//CCL28//ANTIGEN P ENTAT GRP |
10 | 0.0000089344 | CXCR3//CXCL10//CXCL9 |